Tag

Estrogen

All articles tagged with #estrogen

health17 days ago

Rethinking Perimenopause: New Research, Treatments, and Access Gaps

Penn Medicine researchers describe perimenopause as a distinct transitional phase with symptoms like mood changes, sleep disruption, and brain fog, highlighting evolving treatment views as estrogen therapy regains attention after FDA changes, while noting prescribing variation by specialty and insurance disparities. The work also aims to uncover brain mechanisms and markers to predict who benefits from hormone therapy and other treatments, emphasizing early consultation with specialists for personalized care.

Early menopause may foreshadow faster brain aging and earlier Alzheimer’s onset
neuroscience1 month ago

Early menopause may foreshadow faster brain aging and earlier Alzheimer’s onset

An observational study of 2,603 older women followed for up to 18 years finds that earlier menopause is linked to faster cognitive decline and earlier Alzheimer’s diagnosis, with stronger effects after surgical menopause and evidence of greater white matter damage decades later; results suggest longer lifetime exposure to reproductive hormones may help protect brain health, but causality cannot be established.

Timing Matters: Midlife Hormone Therapy Linked to Lower Dementia Risk
health1 month ago

Timing Matters: Midlife Hormone Therapy Linked to Lower Dementia Risk

A UK study of about 180,000 postmenopausal women suggests hormone replacement therapy may modestly lower dementia risk, especially when started in midlife (ages 46–56). Benefits appear limited for older women, reinforcing a 'window of opportunity' for brain protection. The findings are observational and not a placebo-controlled trial, but they align with a growing view that early HRT can be beneficial, while late initiation may offer little or no protection; decisions should weigh individual risks and consult a doctor.

Cycle-aware medicines: how menstruation shapes drug effectiveness
health1 month ago

Cycle-aware medicines: how menstruation shapes drug effectiveness

New evidence suggests women's menstrual cycles and fluctuating estrogen can alter how drugs are processed and how effective they are, with cycle phase influencing outcomes from vaccines to other medications. Estrogen modulates liver enzymes (CYPs) and brain blood flow, meaning the menstrual cycle should be treated as a variable rather than background noise in medical research. Early animal and small human data show higher drug uptake or different responses when estrogen is high, underscoring the need for cycle-aware pharmacology and more studies across medications.

Menopause Hormone Therapy May Lower Alzheimer's Pathology, Stanford Study Shows
health1 month ago

Menopause Hormone Therapy May Lower Alzheimer's Pathology, Stanford Study Shows

A Stanford Neurology study analyzing post-mortem and living participants found estrogen-only menopausal hormone therapy is associated with about a 35% lower risk of Alzheimer's pathology and 39% lower odds of dementia, with living users showing better memory and function. The work suggests possible neuroprotective effects of estrogen and potential greater benefit if started near menopause, but as an observational study it cannot prove causation, and randomized trials are needed to confirm brain-health benefits.

Estrogen-Only Menopause Therapy Linked to Lower Alzheimer's Risk, Study Finds
health1 month ago

Estrogen-Only Menopause Therapy Linked to Lower Alzheimer's Risk, Study Finds

A Stanford-led analysis of brain autopsies from about 21,000+ women found that estrogen-only menopause hormone therapy was associated with roughly a 35% lower lifetime risk of Alzheimer's disease compared with non-users, suggesting a modest protective brain effect for some women. The study notes this is associative, not proof of causation, and results do not necessarily apply to estrogen-plus-progestin or topical forms; benefits may be most relevant to women who started therapy near menopause and who had hysterectomies.

Midlife Brain Fog: Distinguishing ADHD from Perimenopause
health3 months ago

Midlife Brain Fog: Distinguishing ADHD from Perimenopause

The article explains that midlife brain fog can be caused by hormonal changes during perimenopause or by ADHD, with estrogen and dopamine playing key roles in mood, sleep, memory and focus. ADHD typically begins in childhood, while perimenopause-related cognitive changes appear later, but the two can overlap or even be present together. For those unsure, tracking symptoms over weeks (including pattern across cycles, sleep, work and home life) and discussing detailed examples with a clinician can help determine whether ADHD, perimenopause, or both, warrants specific support.

Brain estrogen in both sexes shapes memory's resilience to stress
neuroscience3 months ago

Brain estrogen in both sexes shapes memory's resilience to stress

Researchers in mice show that estrogen produced in the hippocampus alters memory after acute stress in a sex- and cycle-dependent way: high hippocampal estrogen in males and proestrus females worsened memory, while estrus females with lower estrogen were more resilient. The findings suggest estrogen receptors regulate chromatin and memory-related genes, with potential implications for PTSD risk and aging in humans—especially during perimenopause—though further study is needed.

Menopause Reframes the Brain: Resting Networks Reorganize Across Midlife
science4 months ago

Menopause Reframes the Brain: Resting Networks Reorganize Across Midlife

A two-year study tracking resting-state brain activity across premenopause, perimenopause, and postmenopause found widespread, estrogen-linked changes in functional networks, indicating menopause is a neurological transition that may explain short-term cognitive symptoms and influence long-term brain aging. The work, published in Menopause, emphasizes that resting-state measurements reveal brain reorganization not captured by task-based tests and notes ongoing trials comparing natural hormonal trajectories with hormone therapy to protect brain health as women age; with about 6,000 US women entering menopause daily, the findings have broad public-health implications.

Estrogen Loss May Erode the Brain's ECM, Elevating Women's Alzheimer's Risk
science4 months ago

Estrogen Loss May Erode the Brain's ECM, Elevating Women's Alzheimer's Risk

A preclinical Northwestern study shows that postmenopausal estrogen loss, aging, and female sex drive degradation of the hippocampal extracellular matrix (ECM), weakening the brain's supportive scaffold and potentially increasing Alzheimer's risk in women; findings suggest therapies focused on ECM repair or brain estrogen signaling rather than solely clearing amyloid plaques.

Trauma Hit During High Estrogen Predicts PTSD Risk
science6 months ago

Trauma Hit During High Estrogen Predicts PTSD Risk

A new study links the brain’s estrogen levels at the moment of trauma to PTSD risk: high hippocampal estrogen boosts neural plasticity, enabling more intense, lasting traumatic memories in both sexes, with memory disruption persisting longer in females due to receptor differences; the work suggests future treatments could target estrogen signaling to reduce long-term trauma effects.

Medications That May Trigger Gynecomastia in Men
health6 months ago

Medications That May Trigger Gynecomastia in Men

An article lists 10 medicines linked to gynecomastia in men, explaining how hormone balance shifts—lower testosterone, higher estrogen, or raised prolactin—can enlarge breast tissue. Drugs highlighted include spironolactone, finasteride, anabolic steroids, antipsychotics, nonsteroidal antiandrogens, diazepam, cimetidine, ketoconazole, and metronidazole. In many cases the condition resolves after stopping the drug, but it can linger and may require treatment or surgery in some men.

Doctors Urge Expanded Awareness of Hormone Replacement Therapy for Women
health-and-fitness6 months ago

Doctors Urge Expanded Awareness of Hormone Replacement Therapy for Women

Doctors say estrogen replacement can benefit many women by addressing hormonal fluctuations that affect the menstrual cycle, heart, bones, and brain; despite past fears from the Women’s Health Initiative and FDA warnings, updated research and guidance are expanding who should consider HRT, with estrogen levels that can require multiple tests to monitor; it's never too late to start for postmenopausal or younger patients experiencing imbalance.